Patients with idiopathic pulmonary fibrosis in the Yale cohort had higher proportions of CD14+ monocytes (of PBMCs) than healthy controls (p=0·014, figure 2), with percentage of CD14+ cells increasing as mortality risk increased (n=20). Here, CD14 is linked to pulmonary fibrosis.